ISRCTN10335153
Completed
未知
A double-blind, multicentric, multinational randomised study to assess the effects of two years administration of 2 g per day of strontium ranelate versus alendronate 70 mg per week in women with postmenopausal osteoporosis on bone geometry and bone strength measured by peripheral-Quantitative Computed Tomography (p-QCT).
Institut de Recherches Internationales Servier (France)0 sites80 target enrollmentSeptember 17, 2007
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Institut de Recherches Internationales Servier (France)
- Enrollment
- 80
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
2010 results in https://www.ncbi.nlm.nih.gov/pubmed/20512336/
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Women of at least 50 years old
- •2\. Post\-menopausal for at least 5 years
- •3\. Osteoporosis
Exclusion Criteria
- •1\. Evolutive cancer during the past 5 years with a risk of bone metastases
- •2\. Body Mass Index less than 18 or greater than 30 kg/m^2
- •3\. Severe malabsorption
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A double-blind, multicentric, multinational randomised study to assess the effects of one year administration of 2 g per day of strontium ranelate versus marketed bisphosphonates in women with postmenopausal osteoporosis on bone microarchitecture as measured by high-resolution peripheral-quantitative computed tomography (p-QCT)ISRCTN82719233Institut de Recherches Internationales Servier (France)72
Completed
Not Applicable
Cold oxygenated machine preservation of aged renal donation after cardiovascular death transplantsMachine perfusion preservation techniques of kidney graftsInjury, Occupational Diseases, PoisoningISRCTN32967929niversity of Oxford (UK)197
Completed
Not Applicable
A double-blind, multicentre, international randomised study to assess the effects of 6 months or 12 months administration of strontium ranelate versus biphosphonates on bone remodelling and bone safety assessed by histomorphometry in women with postmenopausal osteoporosisPostmenopausal osteoporosis in womenMusculoskeletal DiseasesOsteoporosisISRCTN50493318Institut de Recherches Internationales Servier (France)387
Completed
Phase 2
A Phase II, Open-label, Randomized, Multicenter Study to Assess the Safety and Cardiovascular Effects of Myocell™ Implantation by a Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s)ISRCTN17181395Bioheart Inc. (USA)46
Active, not recruiting
Not Applicable
Effects of strontium ranelate on bone quality before dental implantatioDental implantation in osteoporotic patients or in patients at risk of osteoporotic fractureMedDRA version: 14.1Level: PTClassification code 10064143Term: Dental implantationSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Surgical Procedures, Operative [E04]EUCTR2011-002370-23-DEInstitut de Recherches Internationales Servier60